France won’t pay for weight loss drug Wegovy. What about other European countries?
France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...
Fierce Healthcare3d
CBO: Covering anti-obesity drugs could cost Medicare $35B by 2034
Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...
Analysis reveals higher cost of anti-obesity drugs compared to surgery
The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) ...
The Local5d
French healthcare system won’t pay for new anti-obesity drug
New-generation anti-obesity drug Wegovy, made by the same company that created Ozempic, is now available in France – but it ...
News Medical on MSN6d
Weekly injections of anti-obesity medications cost more than surgery
The cost of taking weekly injections of popular anti-obesity medications liraglutide ... providing important new ...
Is the U.S. at a Turning Point on Obesity?
An obesity expert weighs in on intriguing new data and new drugs that hold promise in the battle against a stubborn problem.
Benefits Pro10d
The debate over obesity treatment: Drugs vs. lifestyle changes
Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...
STAT12d
Pharmalittle: We’re reading about CVS exploring a breakup, obesity drug coverage, and more
CVS Health is exploring options that could include a breakup of the company to separate its retail and insurance units ...